Back to User profile » Dr Yanliang Bai
Papers published by Dr Yanliang Bai:
Screening of a Prognostic Gene Signature for Relapsed/Refractory Acute Myeloid Leukemia Based on Altered Circulating CircRNA Profiles
Guo H, Cui Y, Bai Y, Yan F, Zhang W, Chen Y, Shi M
International Journal of General Medicine 2024, 17:2967-2979
Published Date: 8 July 2024
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Prognostic Significance of C-Reactive Protein to Albumin Ratio in Newly Diagnosed Acute Myeloid Leukaemia Patients
Dou L, Shi M, Song J, Niu X, Niu J, Wei S, Li D, Bai Y, Sun K
Cancer Management and Research 2022, 14:303-316
Published Date: 25 January 2022
Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia
Pei Y, Shi M, Song J, Niu X, Wei S, Dou L, Xiao M, Li D, Xu F, Bai Y, Sun K
Cancer Management and Research 2021, 13:4135-4146
Published Date: 21 May 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Validation of the EUTOS Long-Term Survival Score in Chinese Chronic Myeloid Leukemia Patients Treated with Imatinib: A Multicenter Real-World Study
Yang X, Bai Y, Shi M, Zhang W, Niu J, Wu C, Zhang L, Xu Z, Liu X, Chen Y, Sun K
Cancer Management and Research 2020, 12:1293-1301
Published Date: 20 February 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells
Shi M, Xu F, Yang X, Bai Y, Niu J, Drokow EK, Chen M, Chen Y, Sun K
Cancer Management and Research 2019, 11:8229-8238
Published Date: 6 September 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia
Yu R, Zhang J, Zang Y, Zeng L, Zuo W, Bai Y, Liu Y, Sun K, Liu Y
Cancer Management and Research 2019, 11:7047-7063
Published Date: 25 July 2019